Canada markets closed

Biofrontera AG (B8FK.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
2.99500.0000 (0.00%)
At close: 05:36PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 18.20M
Enterprise Value 15.95M
Trailing P/E 0.32
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.30
Price/Book (mrq)1.05
Enterprise Value/Revenue 0.53
Enterprise Value/EBITDA -6.98

Trading Information

Stock Price History

Beta (5Y Monthly) 0.59
52-Week Change 3-83.22%
S&P500 52-Week Change 322.55%
52 Week High 318.9000
52 Week Low 32.3500
50-Day Moving Average 34.4867
200-Day Moving Average 38.2020

Share Statistics

Avg Vol (3 month) 31.7k
Avg Vol (10 day) 35.18k
Shares Outstanding 56.08M
Implied Shares Outstanding 66.08M
Float 8646.39k
% Held by Insiders 130.17%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 20.047619:1
Last Split Date 3May 14, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 1.32%
Operating Margin (ttm)-43.74%

Management Effectiveness

Return on Assets (ttm)9.15%
Return on Equity (ttm)2.33%

Income Statement

Revenue (ttm)30.16M
Revenue Per Share (ttm)10.00
Quarterly Revenue Growth (yoy)-36.00%
Gross Profit (ttm)N/A
EBITDA 4.24M
Net Income Avi to Common (ttm)398k
Diluted EPS (ttm)9.4500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.64M
Total Cash Per Share (mrq)0.54
Total Debt (mrq)1.04M
Total Debt/Equity (mrq)6.00%
Current Ratio (mrq)1.61
Book Value Per Share (mrq)5.68

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A